# OnCo record bladder-symptoms-and-infection-after-intravesical-therapy (protocol). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/protocols/bladder-symptoms-and-infection-after-intravesical-therapy/>
  a schema:MedicalGuideline ;
  onco:kind "protocol" ;
  schema:identifier "bladder-symptoms-and-infection-after-intravesical-therapy" ;
  schema:name "Bladder symptoms and BCG infection after intravesical therapy for non-muscle-invasive bladder cancer"@en ;
  schema:alternateName "BCG cystitis"@en, "BCG side effects"@en, "BCG toxicity management"@en, "BCG sepsis"@en, "BCGosis"@en, "systemic BCG infection"@en, "bladder irritation after BCG"@en, "side effects of bladder instillations"@en, "intravesical therapy side effects"@en, "bladder spasm after nadofaragene"@en, "TAR-200 urinary side effects"@en ;
  schema:description "Treatments put into the bladder for early bladder cancer, such as BCG, often irritate it: burning, passing urine often or urgently, and some blood in the urine. After BCG this usually settles within 1 to 3 days. Rarely the BCG bacteria cause a serious infection. A high temperature for more than 48 hours, or feeling very unwell, means contacting your doctor immediately."@en ;
  schema:url <https://onco.cc/protocols/bladder-symptoms-and-infection-after-intravesical-therapy/> ;
  schema:dateModified "2026-11-18"^^xsd:date ;
  onco:related <https://onco.cc/drugs/levofloxacin/> ;
  onco:cancers <https://onco.cc/cancers/non-muscle-invasive-bladder-cancer/> ;
  onco:drugs <https://onco.cc/drugs/bcg-intravesical/>, <https://onco.cc/drugs/nadofaragene-firadenovec/>, <https://onco.cc/drugs/nogapendekin-alfa/>, <https://onco.cc/drugs/tar-200/> ;
  onco:terms <https://onco.cc/terms/intravesical-therapy/>, <https://onco.cc/terms/bcg-unresponsive/>, <https://onco.cc/terms/turbt/> .
